It looks like Lilly's claims about their new drug are overblown. I could not read the article because it was behind a paywall, but evidently their results are much less impressive than what the headlines are saying.
Maybe that's why AVXL is up so much today.
(1)
(0)
Anavex Life Sciences Corp. (AVXL) Stock Research Links